170 related articles for article (PubMed ID: 25091987)
41. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
42. Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
de Castro E Gloria H; Jesuíno Nogueira L; Bencke Grudzinski P; da Costa Ghignatti PV; Guecheva TN; Motta Leguisamo N; Saffi J
BMC Cancer; 2021 Apr; 21(1):448. PubMed ID: 33888065
[TBL] [Abstract][Full Text] [Related]
43. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
[TBL] [Abstract][Full Text] [Related]
44. Sequence-dependent effect of a cyclooxygenase-2 inhibitor on topoisomerase I inhibitor and 5-fluorouracil-induced cytotoxicity of colon cancer cells.
Chen WS; Liu JH; Liu JM; Lin JK
Anticancer Drugs; 2004 Mar; 15(3):287-94. PubMed ID: 15014363
[TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms of sequence-dependent antitumor effects of SN-38 and 5-fluorouracil combination therapy against colon cancer cells.
Torigoe S; Ogata Y; Matono K; Shirouzu K
Anticancer Res; 2009 Jun; 29(6):2083-9. PubMed ID: 19528468
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.
Russo A; Maiolino S; Pagliara V; Ungaro F; Tatangelo F; Leone A; Scalia G; Budillon A; Quaglia F; Russo G
Oncotarget; 2016 Nov; 7(48):79670-79687. PubMed ID: 27835895
[TBL] [Abstract][Full Text] [Related]
47. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
[TBL] [Abstract][Full Text] [Related]
48. Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Yazawa Y; Tsunoda S; Furukawa Y
Oncol Res; 2000; 12(3):137-48. PubMed ID: 11216672
[TBL] [Abstract][Full Text] [Related]
49. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
[TBL] [Abstract][Full Text] [Related]
50. The combined effects of proglumide and fluorouracil on the growth of murine Colon 38 cancer cells in vitro.
Mełeń-Mucha G; Ławnicka H; Mucha S
Endokrynol Pol; 2005; 56(6):933-8. PubMed ID: 16821214
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of beta-catenin and KRAS expressions by Piper betle in azoxymethane-induced colon cancer of male Fischer 344 rats.
Esa F; Ngah WZ; Jamal AR; Mohd Yusof YA
Anal Quant Cytopathol Histpathol; 2013 Dec; 35(6):324-34. PubMed ID: 24617038
[TBL] [Abstract][Full Text] [Related]
52. Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
Fujita H; Kato J; Horii J; Harada K; Hiraoka S; Shiraha H; Sakaguchi K; Shiratori Y
Oncol Rep; 2007 Nov; 18(5):1129-37. PubMed ID: 17914563
[TBL] [Abstract][Full Text] [Related]
53. Fraxetin induces cell death in colon cancer cells via mitochondria dysfunction and enhances therapeutic effects in 5-fluorouracil resistant cells.
Lee M; Yang C; Park S; Song G; Lim W
J Cell Biochem; 2022 Feb; 123(2):469-480. PubMed ID: 34816480
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
[TBL] [Abstract][Full Text] [Related]
55. Anticancer activity of an extract from needles and twigs of Taxus cuspidata and its synergistic effect as a cocktail with 5-fluorouracil.
Shang W; Qiao J; Gu C; Yin W; Du J; Wang W; Zhu M; Han M; Lu W
BMC Complement Altern Med; 2011 Dec; 11():123. PubMed ID: 22132732
[TBL] [Abstract][Full Text] [Related]
56. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.
Sasaki K; Tsuno NH; Sunami E; Tsurita G; Kawai K; Okaji Y; Nishikawa T; Shuno Y; Hongo K; Hiyoshi M; Kaneko M; Kitayama J; Takahashi K; Nagawa H
BMC Cancer; 2010 Jul; 10():370. PubMed ID: 20630104
[TBL] [Abstract][Full Text] [Related]
57. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
[TBL] [Abstract][Full Text] [Related]
59. Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells.
Kamran S; Sinniah A; Chik Z; Alshawsh MA
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327333
[TBL] [Abstract][Full Text] [Related]
60. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
